Connect Biopharma Holdings Limited
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
175.01 |
282.56 |
36.41 |
54.61 |
289.46 |
679.54 |
| Przychód Δ r/r |
0.00% |
61.45% |
-87.11% |
50.00% |
430.01% |
134.76% |
| Przychód (min) |
175.01 |
282.56 |
36.41 |
54.61 |
289.46 |
679.54 |
| Przychód (max) |
175.01 |
282.56 |
36.41 |
54.61 |
289.46 |
679.54 |
| EBITDA (średnia) |
109.82 |
177.31 |
22.85 |
34.27 |
181.64 |
426.42 |
| EBIT (średnia) |
109.82 |
177.31 |
22.85 |
34.27 |
181.64 |
426.42 |
| EBIT % |
62.75% |
62.75% |
62.75% |
62.75% |
62.75% |
62.75% |
| Zysk netto (średni) |
-92.22 |
-361.77 |
-343.68 |
-306.18 |
-269.72 |
-144.93 |
| Zysk netto % |
-52.69% |
-128.04% |
-943.92% |
-560.62% |
-93.18% |
-21.33% |
| EPS (średnia) |
-1.67 |
-6.55 |
-6.22 |
-6.01 |
-4.89 |
-2.62 |
| Liczba analityków (Przychody) |
1 |
1 |
2 |
3 |
1 |
2 |
| Liczba analityków (EPS) |
1 |
2 |
2 |
3 |
1 |
1 |
| symbol |
CNTB |
CNTB |
CNTB |
CNTB |
CNTB |
CNTB |